PIVUS

News

  • Monday, June 4, 2012 13:00 Rosensalen, Akademiska sjukhuset entrance 95/96, Uppsala Li, Hao In vitro Studies of Genodermatoses Affecting Cytoskeletal Integrity and Lipid Processing in Human Epidermis: Pathogenic Mechanisms and Effects of Retinoid Therapy [Free fulltext] [More information]
  • Tuesday, June 5, 2012 09:00 Enghoffsalen, Akademiska sjukhuset, ingång 50, bv, Uppsala Eriksson, Niclas On the Prediction of Warfarin Dose [Free fulltext] [More information]

  • Lood, C., Allhorn, M., Lood, R., Gullstrand, B., Olin, A. et al. (2012). IgG glycan hydrolysis by EndoS diminishes the pro-inflammatory properties of immune complexes from patients with SLE - a possible new treatment?. Arthritis and Rheumatism Epub ahead of print. [DOI] [More information]
  • Rudin, A., Sturfelt, G., Carlsten, H., Hafström, I., Lundberg, I. et al. (2012). [Rheumatologic research with animal experiments is important for our patients].. Läkartidningen, 109(1-2): 40- [More information]
  • De Caterina, R., Husted, S., Wallentin, L., Andreotti, F., Arnesen, H. et al. (2012). New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes: ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease Position Paper. Journal of the American College of Cardiology, 59(16): 1413-1425 [DOI] [More information]
  • Farrokhnia, N., Göransson, K. (2011). Swedish emergency department triage and interventions for improved patient flows: a national update. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 19: 72- [DOI] [Free fulltext] [More information]

PIVUS - Prospective Investigation of the Vasculature in Uppsala Seniors

The PIVUS study started in 2001 with the primary aim to investigate the predicive power of different measurements of endothelial function and arterial compliance in a random sample of 1000 subjects aged 70 living in the community of Uppsala. As secondary aims, the study also included measurements of cardiac function and structure by ultrasound and MRI, evaluation of atherosclerosis by ultrasound and MRI, 7 day food intake recordings, detailed ECG analysis, cardiovascular autonomic function, body composition by DXA, DNA analysis and lung function, as well as a number of biochemical markers.

The inclusion of subjects in the study was completed in June 2004 by the team below:

 
          Anna Stenborg, Kerstin Marttala, Lars Lind, Jan Hall

In March 2006 a reinvesigation of the cohort at the age of 75 was started. The major measurements performed at age 70 will be repeated at age 75. In addition, we will focus on infarcts in the brain and heart, so both of these items will be investigated by brain and myocardial MRI in all subjects. Also cognitive tests are included in the reinvestigation that was completed in September 2009.Of the initial 1016 subjects, 52 had died during the 5 years and 827 attended the re-examination at age 75.

Print

MRI angiography, supplied by Håkan Ahlström and Lars Johansson, Dept. of Radiology